{"id":31835,"date":"2023-10-11T08:02:00","date_gmt":"2023-10-11T08:02:00","guid":{"rendered":"https:\/\/celonpharma.com\/?p=31835"},"modified":"2023-10-11T08:02:34","modified_gmt":"2023-10-11T08:02:34","slug":"current-report-23-2023-correction-of-the-periodical-report","status":"publish","type":"post","link":"https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/","title":{"rendered":"Current report No. 23\/2023 \u2013 Correction of the Periodical Report"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical information<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Management Board of Celon Pharma S.A. (\u201cCompany\u201d) hereby informs that in the \u201cHalf-Year Condensed Financial Statements for the 6-month period ended June 30, 2023\u201d published by the Company on 20 September 2023, there was, for technical reasons, a mistake in the presentation of data for the period April 1-June 30 2022 in the Statement of Comprehensive Income and in the Segment Note.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Immediately following the publication of this current report, the Company will publish a revised periodical report for 1H2023, as required by Article 15 (4) of the Regulation of the Minister of Finance of March 29, 2018 on current and periodic information provided by issuers of securities (&#8230;). The appendix to this current report presents the tables with the revised data<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical information The Management Board of Celon Pharma S.A. (\u201cCompany\u201d) hereby informs that in the \u201cHalf-Year Condensed Financial Statements for the 6-month period ended June 30, 2023\u201d published by the Company on 20 September 2023, there was, for<a class=\"excerpt-read-more float-right\" href=\"https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/\" title=\"ReadCurrent report No. 23\/2023 \u2013 Correction of the Periodical Report\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":31,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[46],"tags":[],"class_list":["post-31835","post","type-post","status-publish","format-standard","hentry","category-current-reports"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Current report No. 23\/2023 \u2013 Correction of the Periodical Report - Celon Pharma<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Current report No. 23\/2023 \u2013 Correction of the Periodical Report - Celon Pharma\" \/>\n<meta property=\"og:description\" content=\"Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical information The Management Board of Celon Pharma S.A. (\u201cCompany\u201d) hereby informs that in the \u201cHalf-Year Condensed Financial Statements for the 6-month period ended June 30, 2023\u201d published by the Company on 20 September 2023, there was, forRead more &raquo;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/\" \/>\n<meta property=\"og:site_name\" content=\"Celon Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-11T08:02:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-11T08:02:34+00:00\" \/>\n<meta name=\"author\" content=\"Paulina Dobies\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Paulina Dobies\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-23-2023-correction-of-the-periodical-report\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-23-2023-correction-of-the-periodical-report\\\/\"},\"author\":{\"name\":\"Paulina Dobies\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/e86806fa37010f6a01f6fc388950174b\"},\"headline\":\"Current report No. 23\\\/2023 \u2013 Correction of the Periodical Report\",\"datePublished\":\"2023-10-11T08:02:00+00:00\",\"dateModified\":\"2023-10-11T08:02:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-23-2023-correction-of-the-periodical-report\\\/\"},\"wordCount\":136,\"articleSection\":[\"Current reports\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-23-2023-correction-of-the-periodical-report\\\/\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-23-2023-correction-of-the-periodical-report\\\/\",\"name\":\"Current report No. 23\\\/2023 \u2013 Correction of the Periodical Report - Celon Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\"},\"datePublished\":\"2023-10-11T08:02:00+00:00\",\"dateModified\":\"2023-10-11T08:02:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/e86806fa37010f6a01f6fc388950174b\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-23-2023-correction-of-the-periodical-report\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-23-2023-correction-of-the-periodical-report\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/current-report-23-2023-correction-of-the-periodical-report\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Current report No. 23\\\/2023 \u2013 Correction of the Periodical Report\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/\",\"name\":\"Celon Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/celonpharma.com\\\/en\\\/#\\\/schema\\\/person\\\/e86806fa37010f6a01f6fc388950174b\",\"name\":\"Paulina Dobies\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Current report No. 23\/2023 \u2013 Correction of the Periodical Report - Celon Pharma","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/","og_locale":"en_US","og_type":"article","og_title":"Current report No. 23\/2023 \u2013 Correction of the Periodical Report - Celon Pharma","og_description":"Legal basis: Article 56 subs. 1 point 2 of the Act on Public Offering \u2013 current and periodical information The Management Board of Celon Pharma S.A. (\u201cCompany\u201d) hereby informs that in the \u201cHalf-Year Condensed Financial Statements for the 6-month period ended June 30, 2023\u201d published by the Company on 20 September 2023, there was, forRead more &raquo;","og_url":"https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/","og_site_name":"Celon Pharma","article_published_time":"2023-10-11T08:02:00+00:00","article_modified_time":"2023-10-11T08:02:34+00:00","author":"Paulina Dobies","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Paulina Dobies","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/#article","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/"},"author":{"name":"Paulina Dobies","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/e86806fa37010f6a01f6fc388950174b"},"headline":"Current report No. 23\/2023 \u2013 Correction of the Periodical Report","datePublished":"2023-10-11T08:02:00+00:00","dateModified":"2023-10-11T08:02:34+00:00","mainEntityOfPage":{"@id":"https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/"},"wordCount":136,"articleSection":["Current reports"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/","url":"https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/","name":"Current report No. 23\/2023 \u2013 Correction of the Periodical Report - Celon Pharma","isPartOf":{"@id":"https:\/\/celonpharma.com\/en\/#website"},"datePublished":"2023-10-11T08:02:00+00:00","dateModified":"2023-10-11T08:02:34+00:00","author":{"@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/e86806fa37010f6a01f6fc388950174b"},"breadcrumb":{"@id":"https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/celonpharma.com\/en\/current-report-23-2023-correction-of-the-periodical-report\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/celonpharma.com\/en\/"},{"@type":"ListItem","position":2,"name":"Current report No. 23\/2023 \u2013 Correction of the Periodical Report"}]},{"@type":"WebSite","@id":"https:\/\/celonpharma.com\/en\/#website","url":"https:\/\/celonpharma.com\/en\/","name":"Celon Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/celonpharma.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/celonpharma.com\/en\/#\/schema\/person\/e86806fa37010f6a01f6fc388950174b","name":"Paulina Dobies"}]}},"_links":{"self":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/31835","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/comments?post=31835"}],"version-history":[{"count":2,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/31835\/revisions"}],"predecessor-version":[{"id":31837,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/posts\/31835\/revisions\/31837"}],"wp:attachment":[{"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/media?parent=31835"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/categories?post=31835"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/celonpharma.com\/en\/wp-json\/wp\/v2\/tags?post=31835"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}